Stevens Christopher James bought RCKT
August 4, 2025 · Form 4 insider transaction
Stevens Christopher James bought 407,166 shares of Rocket Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
407,166
Price
$0.00
Total value
N/A
InsiderStevens Christopher James
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateAugust 4, 2025
Filing dateAugust 6, 2025
Shares owned after407,166
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Holdings are Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on August 4, 2026, with the remaining shares vesting in equal quarterly installments over the following two years.